Melissa M Damschroder (Melissa Damschroder)

Scopus Author ID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 3

Top Topics

Metabolic Syndrome

Monoclonal Antibody

Top Venues

Science translational medicine

MedImmune LLC

This page only lists publications with an associated author ORCID identifier.

Affiliation History

MedImmune LLC Sep 03 1991

United States

Associate Director R&D :: Antibody Dscovery & Protein Engineering

National Cancer Institute

United States

Researcher GS11 step3

Food and Drug Administration, NIH

United States

Researcher GS11 step 3

Medical College of Ohio

United States

Researcher

Publications

John E Le Lay, Qun Du, Minal B Mehta, Nicholas Bhagroo, B Timothy Hummer, Judith Falloon, Glenn Carlson, Anton I Rosenbaum, ChaoYu Jin, Holly Kimko, Lan-Feng Tsai, Steven J Novick, Bill Cook, Chang Yeop Han, Chang Yeop Han, Tomas Vaisar, Alan Chait, Sotirios K Karathanasis, Christopher J Rhodes, Boaz Hirshberg, Melissa M Damschroder, Judith Hsia, Joseph S Grimsby
Blocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trial. Science translational medicine 13 (590) (2021)
Qun Du, Melissa M Damschroder, Timothy M Pabst, Alan K Hunter, William K Wang, Haibin Luo
Process optimization and protein engineering mitigated manufacturing challenges of a monoclonal antibody with liquid-liquid phase separation issue by disrupting inter-molecule electrostatic interactions. mAbs 11 (4) (2019)
Reena Varkey, Qun Du, Jodi L Karnell, Xiaodong Xiao, Kerry A Casey, Rob Woods, Kim Rosenthal, Susan Wilson, William F Dall'Acqua, Herren Wu, Ronald Herbst, Rachel Ettinger, Melissa M Damschroder
Discovery and characterization of potent IL-21 neutralizing antibodies via a novel alternating antigen immunization and humanization strategy. PloS one 14 (1) (2019)